Published in Oral Oncol on January 01, 1998
Oral Mucositis and Laser Therapy Associated With Photodynamic Therapy (OMLTPT) | NCT02555501
Chemotherapy-induced and/or radiation therapy-induced oral mucositis--complicating the treatment of cancer. Neoplasia (2004) 1.38
Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer (2012) 1.27
Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies. Support Care Cancer (2006) 1.16
Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting. PLoS One (2011) 1.12
Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis. Dig Dis Sci (2004) 1.05
Normal tissue protection for improving radiotherapy: Where are the Gaps? Transl Cancer Res (2012) 1.03
Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients. Support Care Cancer (2013) 1.02
A review of the anticancer and immunomodulatory effects of Lycium barbarum fruit. Inflammopharmacology (2011) 1.00
Current practice and knowledge of oral care for cancer patients: a survey of supportive health care providers. Support Care Cancer (2004) 1.00
Oral mucositis in cancer treatment: Natural history, prevention and treatment. Mol Clin Oncol (2014) 0.96
Anti-inflammatory cytokines: important immunoregulatory factors contributing to chemotherapy-induced gastrointestinal mucositis. Chemother Res Pract (2012) 0.95
Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis. Onco Targets Ther (2014) 0.93
Gastrointestinal mucositis: a new biological model. Support Care Cancer (2003) 0.92
Apoptotic and inflammation markers in oral mucositis in head and neck cancer patients receiving radiotherapy: preliminary report. Support Care Cancer (2008) 0.91
Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis. Support Care Cancer (2006) 0.90
Cancer treatment-induced mucositis pain: strategies for assessment and management. Ther Clin Risk Manag (2006) 0.89
Oral mucositis induced by anticancer treatments: physiopathology and treatments. Ther Clin Risk Manag (2006) 0.89
Traumeel S in preventing and treating mucositis in young patients undergoing SCT: a report of the Children's Oncology Group. Bone Marrow Transplant (2012) 0.88
Anti-inflammatory agents in the management of alimentary mucositis. Support Care Cancer (2006) 0.87
Transforming Growth Factor-beta2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling. Br J Cancer (2002) 0.86
Topical curcumin can inhibit deleterious effects of upper respiratory tract bacteria on human oropharyngeal cells in vitro: potential role for patients with cancer therapy induced mucositis? Support Care Cancer (2010) 0.86
Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy--a randomized controlled trial. Support Care Cancer (2007) 0.86
Lactoferrin reduces methotrexate-induced small intestinal damage, possibly through inhibition of GLP-2-mediated epithelial cell proliferation. Dig Dis Sci (2004) 0.86
Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial. Br J Cancer (2003) 0.85
Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic cancer. Open Access J Clin Trials (2010) 0.85
Oral health-related quality of life in complete denture wearers depending on their socio-demographic background, prosthetic-related factors and clinical condition. Med Oral Patol Oral Cir Bucal (2013) 0.85
Serum amyloid P ameliorates radiation-induced oral mucositis and fibrosis. Fibrogenesis Tissue Repair (2010) 0.84
Oral mucositis in children suffering from acute lymphoblastic leukaemia. Contemp Oncol (Pozn) (2012) 0.84
The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study. BMC Cancer (2013) 0.83
Risk factors for oral mucositis in paediatric oncology patients receiving alkylant chemotherapy. BMC Oral Health (2006) 0.82
Effects of professional oral health care on reducing the risk of chemotherapy-induced oral mucositis. Support Care Cancer (2014) 0.82
An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamsters. Am J Pathol (2004) 0.82
Assessment of oral cytological changes associated with exposure to chemotherapy and/or radiotherapy. Cytojournal (2009) 0.82
Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy. Support Care Cancer (2011) 0.78
Prevention and management of mucositis in patients with cancer: a review article. Iran J Cancer Prev (2012) 0.78
Review of the complications associated with treatment of oropharyngeal cancer: a guide for the dental practitioner. Quintessence Int (2013) 0.78
Mechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapy. Onco Targets Ther (2016) 0.78
Low body mass index as a risk factor of moderate to severe oral mucositis in oral cancer patients with radiotherapy. Support Care Cancer (2012) 0.78
Absorption and tolerability of fentanyl buccal soluble film (FBSF) in patients with cancer in the presence of oral mucositis. J Pain Res (2011) 0.77
A rat model against chemotherapy plus radiation-induced oral mucositis. Saudi Pharm J (2013) 0.77
Oral health as a predictive factor for oral mucositis. Clinics (Sao Paulo) (2013) 0.77
New pathways for alimentary mucositis. J Oncol (2008) 0.77
γ-Tocotrienol prevents 5-FU-induced reactive oxygen species production in human oral keratinocytes through the stabilization of 5-FU-induced activation of Nrf2. Int J Oncol (2015) 0.77
Chemo-radiotherapy induced oral mucositis during IMRT for head and neck cancer - An assessment. Med Oral Patol Oral Cir Bucal (2015) 0.77
A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens. Support Care Cancer (2011) 0.77
Atorvastatin and trans-caryophyllene for the prevention of leukopenia in an experimental chemotherapy model in Wistar rats. Mol Clin Oncol (2015) 0.76
Increased Ghrelin but Low Ghrelin-Reactive Immunoglobulins in a Rat Model of Methotrexate Chemotherapy-Induced Anorexia. Front Nutr (2016) 0.76
Prevention and management of antineoplastic therapy induced oral mucositis. Natl J Maxillofac Surg (2010) 0.76
Oral health status of chinese paediatric and adolescent oncology patients with chemotherapy in Hong Kong: a pilot study. Open Dent J (2015) 0.75
New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury. Front Pharmacol (2017) 0.75
Palifermin and Chlorhexidine Mouthwashes in Prevention of Chemotherapy-Induced Mucositis in Children with Acute Lymphocytic Leukemia: a Randomized Controlled Trial. J Dent (Shiraz) (2016) 0.75
Escherichia coli Nissle 1917-derived factors reduce cell death and late apoptosis and increase transepithelial electrical resistance in a model of 5-fluorouracil-induced intestinal epithelial cell damage. Cancer Biol Ther (2014) 0.75
Mucositis and salivary antioxidants in patients undergoing bone marrow transplantation (BMT). Med Oral Patol Oral Cir Bucal (2014) 0.75
Toxicity of photodynamic therapy with LED associated to Photogem®: an in vivo study. Lasers Med Sci (2011) 0.75
Rhubarb extract partially improves mucosal integrity in chemotherapy-induced intestinal mucositis. World J Gastroenterol (2016) 0.75
Preventing and Managing Toxicities of High-Dose Methotrexate. Oncologist (2016) 0.75
Evaluation of nystatin containing chitosan hydrogels as potential dual action bio-active restorative materials: in vitro approach. J Funct Biomater (2014) 0.75
Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice. Cancer Med (2016) 0.75
Predictive single nucleotide polymorphism markers for acute oral mucositis in patients with nasopharyngeal carcinoma treated with radiotherapy. Oncotarget (2017) 0.75
Tachykinin peptide, substance P, and its receptor NK-1R play an important role in alimentary tract mucosal inflammation during cytotoxic therapy. Dig Dis Sci (2014) 0.75
Radiation-Induced Oral Mucositis. Front Oncol (2017) 0.75